|
|
M A Becker
J Clin Invest. 1976;
57(2):308
doi:10.1172/JCI108282
Abstract |
Full text
| PDF

I
n the majority of patients with gout and excessive uric acid production, underlying enzyme abnormalities have not been identified. In the present study, measurement of both the rate of generation and concentration of phosphoribosylpyrophosphate (PP-ribose-P) and the concentration of ribose-5-phosphate in cultured cells were undertaken to establish a classification of purine overproducers to direct study of additional enzyme defects. Fibroblasts were cultured from 24 individuals assigned to 4 groups: group 1, 5 normal controls; group 2, 5 patients with gout and normal dialy urinary uric acid excretion (gouty controls); group 3, 7 patients with well-defined enzyme abnormalities and excessive urinary acid excretion (4 with hypoxanthine-guanine phosphoribosyltransferase deficiency and 3 with excessive PP-ribose-P synthetase activity); and group 4, 7 patients with gout and excessive uric acid excretion but without grossly abnormal activities of the above enzymes in erythrocyte lysates. In all 14 fibroblast strains from patients showing excessive production of uric acid (groups 3 and 4), rates of purine synthesis de novo and PP-ribose-P concentrations exceeded values for cells from control groups. Cells from group 3 patients with hypoxanthine-guanine phosphoribosyltransferase deficiency showed normal PP-ribose-P generation, while those with excessive PP-ribose-P synthetase activity demonstrated increased generation of this regulatory substrate. All strains from group 3 patients had normal ribose-5-phosphate concentrations. Five cell strains from group 4 patients showed one of the two patterns of abnormalities in these measurements seen in strains from group 3 patients: two resembled hypoxanthine-guanine phosphoribosyltransferase-deficient cells, and three resembled cells with excessive PP-ribose-P synthetase activity. Analyses of erythrocyte enzyme preparations from two of these patients in group 4 have led to identification of a kinetic variant of each enzyme as predicted from the foregoing patterns. Two additional group 4 cell lines that showed increased ribose-5-phosphate concentrations in addition to increased PP-ribose-P concentrations and generation were classified in a separate subgroup, since in the individuals excessive purine synthesis appeared to result from increases ribose-5-phosphate concentration, leading to increased availability of PP-ribose-P. No abnormality in either hypoxanthine-guanine phosphoribosyltransferase or PP-ribose-P synthetase has been found in erythrocyte preparations from one patient so classified.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I
Rocio Moran, André B.P. Kuilenburg, John Duley, Sander B. Nabuurs, Aditia Retno-Fitri, John Christodoulou, Jeroen Roelofsen, Helger G. Yntema, Neil R. Friedman, Hans van Bokhoven
|
Am. J. Med. Genet.
|
2012 |
Stable Isotope Dilution Mass Spectrometric Assay for PRPP Using Enzymatic Procedures
Y. Shinohara, Y. Suzuki, H. Hasegawa, M. Nakamura, T. Nishiyama, A. Hiratsuka, K. Ichida
|
NUCLEOT NUCL
|
2011 |
PRPS1 Mutations: Four Distinct Syndromes and Potential Treatment
Arjan P.M. de Brouwer, Hans van Bokhoven, Sander B. Nabuurs, Willem Frans Arts, John Christodoulou, John Duley
|
The American Journal of Human Genetics
|
2010 |
Pediatric neurological syndromes and inborn errors of purine metabolism
Marcella Camici, Vanna Micheli, Piero Luigi Ipata, Maria Grazia Tozzi
|
Neurochemistry International
|
2010 |
Novartis Foundation Symposia
Oded Sperling, Pnina Boer, Sara Brosh, Esther Zoref, André de Vries
|
Ciba Foundation Symposium 48 - Purine and Pyrimidine Metabolism
|
2008 |
Novartis Foundation Symposia
Gabrielle H. Reem
|
Ciba Foundation Symposium 48 - Purine and Pyrimidine Metabolism
|
2008 |
Advances in Enzymology - and Related Areas of Molecular Biology
Michael A. Becker, Kari O. Raivio, J. Edwin Seegmiller
|
Advances in Enzymology and Related Areas of Molecular Biology
|
2006 |
Ribose 1,5-bisphosphate is a putative regulator of fructose 6-phosphate/fructose 1,6-bisphosphate cycle in liver
Masaru Sawada, Yuka Mitsui, Hiroshi Sugiya, Shunsuke Furuyama
|
The International Journal of Biochemistry & Cell Biology
|
2000 |
Clinical and biochemical aspects of uric acid overproduction
J. García Puig, F. Antón Mateos
|
Pharm World Sci
|
1994 |
Prognostic implications of renal hypertrophy in diabetes mellitus
Kenneth S. Kleinman, Leon G. Fine
|
Diabetes Metab. Rev.
|
1988 |
|